Generic Drug

(Image: Getty/marchmeena29)

Amneal invests $340m in generics distributor

By Vassia Barba

Amneal announces acquisition of 65.1% majority interest of generics distributing company, AvKARE, boosting its presence in the generics and federal healthcare market.

(Image: Getty/Thida Ratn Caem Caeng  EyeEm)


2018: An inflection point for generics

By Flora Southey

Generics drug portfolios are diversifying, prices are stabilising, and while competition remains intense, the worst of price erosion appears to be over, claims Clarivate Analytics executive.


update - CEO: ideal model is two to four API plants and six to eight drug facilities

Teva confirms plan to reduce workforce by 14,000 to save $3bn

By Gareth Macdonald

Teva Pharmaceutical Industries will reduce its workforce by 14,000, rejig its generics portfolio and speed up optimization of its plant network as part of a $3bn (€2.5bn) cost saving plan.


update - US FDA confirms lifting of import alert

Sun says US FDA poised to lift Mohali import alert

By Gareth Macdonald

Sun Pharmaceutical Industries Ltd has said the US FDA plans to lift the import alert imposed on its manufacturing plant in Mohali, Punjab in India.

Kaleo set to relaunch withdrawn Epipen rival Auvi-Q next year

update - Kaleo wants all patients to have access to Auvi-Q, regardless of insurance coverage

Kaleo set to relaunch withdrawn Epipen rival Auvi-Q next year

By Gareth Macdonald

Kaleo has said it will relaunch Auvi-Q (epinephrine injection) a year after a recall by licensee Sanofi removed the Epipen rival from the market.

Teva sees higher API sales in Q2 (source Google images)

Teva sees API sales surge in Q2

By Gareth Macdonald

Teva Pharmaceutical Industries has reported higher second quarter API revenue citing a surge in demand from customers in the US and Europe.

Vistapharm manufacturing facility in Largo, Florida

Packaging defect prompts VistaPharm oxy recall

By Gareth Macdonald

VistaPharm has recalled thousands of cases of generic oxycodone as a result of a defect that allowed the powerful painkiller to leak out of the packaging.

Alcami CEO Stephan Kutzer announcing the firm's new brand at DCAT Week

dispatches from DCAT Week '16

AAI and CML rebrand as Alcami

By Melissa Fassbender

AAI Pharma Services (AAI) and Cambridge Major Laboratories (CML) have rebranded as Alcami, a contract development and manufacturing organization. 

Image: iStock

CPhI report: enter US market or get left behind

By Melissa Fassbender

The new report indicates that the US CMO market is poised for significant growth and urges international companies to enter the market – or be left behind.

Teva announced last week its plans to acquire Allergan

Success of Allergan integration is the human capital, says Teva

By Angela Coyle

"People are the essence of the company going forward," said Teva, referring to the news that the world's largest generic drug maker will purchase Allergan's generics business for $40.5bn, at its Q2 financial results press conference...


Follow us


View more


Featured Suppliers